European Society for Translational Medicine (EUSTM)
The European Society for Translational Medicine (EUSTM) is a global non-profit neutral platform for the advancement and progress of Translational Medicine by offering high quality educational programs and events to the Society’s members.
The society facilitates cooperation and interaction among clinicians, basic life scientists, academia, industry, governments, funding and regulatory agencies, investors and policy makers in order to develop and deliver high quality translational medicine programs and initiatives with overall aim to enhance the health care of global population.
The society’s goal is to enhance the research and development of novel and affordable diagnostic tools and treatments for clinical disorders affecting global population.
New Horizons in Translational Medicine (ISSN:2307 – 5023)
is the official digital magazine of the European Society for Translational Medicine. New Horizons in Translational Medicine summarize the latest industry trends and developments, highlight R&
D hurdles and present potential solutions to common problems encountered in the Field. New Horizons in Translational Medicine also publishes expert views from key opinion leaders (KOLs) and executives from pharma, biotech and life science industry along with academic leaders. New Horizons in Translational Medicine is published every month and digitally delivered to more than 35
selected global executives, clinical research professionals and key opinion leaders (KOLs) from industry and academia.